Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

The main issue that makes the rational and targeted application of animal models difficult for T1D is that very little is known about the pathogenesis of the human disease. Which beta-cell ...

Contact between the virus and the cell surface is a crucial ... not only to an established influenza A model, but also to a novel influenza strain of animal origin: the H18N11 virus, which is ...

The Indian government is refining biosimilar drug regulations, aligning with global standards to ensure stringent quality in ...

The medical research on human subjects has to respect the ethical principles included in the Declaration of Helsinki and the additional constraints imposed ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system more effectively than traditional therapies, particularly against evasive and ...

Influenza viruses are among the most likely triggers of future pandemics. A research team from the Helmholtz Center for Infection Research (HZI) and the Medical Center—University of Freiburg has ...

Genprex inks sponsored research agreement with the University of Pittsburgh to study diabetes gene therapy in Type 1 and Type 2 diabetes: Austin, Texas Thursday, May 8, 2025, 10:0 ...

Biomedical research in liver diseases has traditionally depended on animal models, but ethical concerns and the quest for ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company”) announced today that its world-leading NAMkind™ platform for liver toxicology prediction, provided as a commercial service to pharma companies, was ...

You’ve worked extensively on respiratory syncytial virus (RSV) and influenza. What are the key differences in how the immune ...